Fortress Biotech Inc.

NASDAQ: FBIO · Real-Time Price · USD
2.11
0.15 (7.65%)
At close: Aug 15, 2025, 3:49 PM

Fortress Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-120.86M -60.64M -213.91M -164.83M
Depreciation & Amortization
4.46M 6M 9.35M 6.79M
Stock-Based Compensation
32.62M 17.03M 22.99M 19.49M
Other Working Capital
-6.21M -4.61M -5.43M 756K
Other Non-Cash Items
11.71M -78.09M 2.89M -14.36M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-8.13M -12.52M -715K 36.37M
Operating Cash Flow
-80.19M -128.22M -179.4M -116.54M
Capital Expenditures
-15M -8.1M -3.06M -16.35M
Cash Acquisitions
n/a n/a -20M 56.86M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -2.04M -213K -11.78M
Investing Cash Flow
-15M -2.1M -22.93M 40.51M
Debt Repayment
-7.33M -36.85M 49.25M -9.64M
Common Stock Repurchased
n/a -400K -1.19M -13K
Dividend Paid
-4.71M -8.77M -8.78M -8.78M
Other Financial Acitivies
-163K -2.48M -6.74M -5.3M
Financial Cash Flow
70.64M 32.74M 75.32M 148.99M
Net Cash Flow
-24.55M -97.59M -127.01M 72.97M
Free Cash Flow
-95.19M -136.32M -182.46M -132.89M